BMRABIOMERICA INC

Nasdaq biomerica.com


$ 0.35 $ 0.01 (2.31 %)    

Monday, 09-Sep-2024 15:03:20 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 0.355
$ 0.34
$ 0.32 x 2,200
-- x --
$ 0.32 - $ 0.37
$ 0.24 - $ 2.13
314,031
na
5.97M
$ -1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-28-2024 05-31-2024 10-K
2 04-12-2024 02-29-2024 10-Q
3 01-16-2024 11-30-2023 10-Q
4 10-12-2023 08-31-2023 10-Q
5 08-25-2023 05-31-2023 10-K
6 04-14-2023 02-28-2023 10-Q
7 01-13-2023 11-30-2022 10-Q
8 10-13-2022 08-31-2022 10-Q
9 08-29-2022 05-31-2022 10-K
10 04-14-2022 02-28-2022 10-Q
11 01-12-2022 11-30-2021 10-Q
12 10-14-2021 08-31-2021 10-Q
13 08-27-2021 05-31-2021 10-K
14 04-14-2021 02-28-2021 10-Q
15 01-14-2021 11-30-2020 10-Q
16 10-15-2020 08-31-2020 10-Q
17 08-31-2020 05-31-2020 10-K
18 04-14-2020 02-29-2020 10-Q
19 01-14-2020 11-30-2019 10-Q
20 10-15-2019 08-31-2019 10-Q
21 08-29-2019 05-31-2019 10-K
22 04-15-2019 02-28-2019 10-Q
23 01-14-2019 11-30-2018 10-Q
24 10-15-2018 08-31-2018 10-Q
25 08-29-2018 05-31-2018 10-K
26 04-16-2018 02-28-2018 10-Q
27 01-16-2018 11-30-2017 10-Q
28 10-16-2017 08-31-2017 10-Q
29 08-29-2017 05-31-2017 10-K
30 04-14-2017 02-28-2017 10-Q
31 01-17-2017 11-30-2016 10-Q
32 10-17-2016 08-31-2016 10-Q
33 08-29-2016 05-31-2016 10-K
34 04-14-2016 02-29-2016 10-Q
35 01-14-2016 11-30-2015 10-Q
36 10-15-2015 08-31-2015 10-Q
37 08-31-2015 05-31-2015 10-K
38 04-14-2015 02-28-2015 10-Q
39 01-14-2015 11-30-2014 10-Q
40 10-15-2014 08-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biomerica-q4-eps-009-up-from-010-yoy-sales-112m-up-from-111m-yoy

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.09) per share. This is a 10 percent increase over losses of $(0.10) pe...

 biomerica-enhances-ibs-diagnostic-test-with-at-home-blood-collection-system

Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced medical products, is proud to announce a major enhancement to its ...

 biomerica-advances-ibs-treatment-with-infoods-product-expands-physician-network-nationwide

Biomerica, Inc. (NASDAQ:BMRA), (the "Company") a global provider of advanced medical products is pleased to announce ad...

 reported-late-friday-biomerica-q3-eps-011-up-from-012-yoy-sales-102m-down-from-111m-yoy

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.11) per share. This is a 8.33 percent increase over losses of $(0.12) ...

 biomerica-received-decision-grant-european-patent-number-ep3497447-titled-compositions-devices-and-methods-of-depression-sensitivity-testing

https://register.epo.org/application?number=EP17825010

 biomerica-has-received-a-decision-to-grant-european-patent-number-ep3449254-titled-compositions-devices-and-methods-of-crohns-disease-sensitivity-testing

https://register.epo.org/application?number=EP17790141 

 biomerica-appoints-jack-kenny-as-chairman-of-the-board

Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcareMr. Kenny most re...

 why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION